Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Mar-24 6:48 PM View:  | Cidara Therapeutics, Inc. (CDTX) | 15-Mar-24 | Grant | 120,000 | -- | -- | 60% 198.77K to 318.77K | |
| 12-Mar-24 9:46 PM View: | Cidara Therapeutics, Inc. (CDTX) | 11-Mar-24 | Sale | 20,473 | $0.67 | $13,712.80 | (9%) 219.24K to 198.77K | |
| 29-Mar-23 5:32 PM View: | Cidara Therapeutics, Inc. (CDTX) | 27-Mar-23 | Grant | 126,667 | -- | -- | 150% 84.58K to 211.24K | |
| 13-Mar-23 9:21 PM View: | Cidara Therapeutics, Inc. (CDTX) | 13-Mar-23 | Private Sale | 4,329 | $1.53 | $6,623.37 | (5%) 88.91K to 84.58K | |
| 04-Apr-22 5:12 PM View: | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-22 | Grant | 104,027 | -- | -- | 100% 0 to 104.03K | |
| 04-Apr-22 5:12 PM View: | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-22 | Payment of Exercise | 23,122 | $0.83 | $19,191.30 | (22%) 104.03K to 80.91K | |
| 02-Jun-20 12:25 PM View: | Bellicum Pharmaceuticals, Inc (BLCM) | 29-May-20 | Payment of Exercise | 107 | $7.63 | $816.41 | (5%) 1.99K to 1.88K | 53% |
| 30-Aug-19 4:01 PM View: | Bellicum Pharmaceuticals, Inc (BLCM) | 29-Aug-19 | Market Purchase | 8,000 | $1.23 | $9,821.60 | 78% 10.29K to 18.29K | (71%) |
| 30-May-19 4:05 PM View: | Bellicum Pharmaceuticals, Inc (BLCM) | 29-May-19 | Payment of Exercise | 1,065 | $2.09 | $2,225.85 | (11%) 10.0K to 8.94K | 83% |
| 29-May-18 9:29 PM View: | Bellicum Pharmaceuticals, Inc (BLCM) | 29-May-18 | Grant | 10,000 | -- | -- | 100% 0 to 10.0K | |
| 12-Feb-18 5:23 PM View: | Aravive, Inc. (ARAV) | 08-Feb-18 | Market Sale | 4,118 | $1.80 | $7,412.40 | (2%) 205.67K to 201.56K | 41% |
| 22-Dec-17 5:14 PM View: | Aravive, Inc. (ARAV) | 20-Dec-17 | Grant | 93,100 | -- | -- | 83% 112.57K to 205.67K | |
| 29-Nov-17 8:56 PM View: | Aravive, Inc. (ARAV) | 28-Nov-17 | Grant | 20,000 | -- | -- | 22% 92.57K to 112.57K | |
| 23-Oct-17 5:01 PM View: | Aravive, Inc. (ARAV) | 19-Oct-17 | Market Sale | 776 | $2.55 | $1,978.80 | (< 1%) 93.35K to 92.57K | 57% |
| 10-Oct-17 8:17 PM View: | Aravive, Inc. (ARAV) | 06-Oct-17 | Grant | 57,000 | -- | -- | 157% 36.35K to 93.35K | |
| 15-Mar-17 5:31 PM View: | Aravive, Inc. (ARAV) | 15-Mar-17 | Market Sale | 776 | $19.02 | $14,759.50 | (2%) 37.13K to 36.35K | 94% |
| 15-Mar-17 5:31 PM View: | Aravive, Inc. (ARAV) | 14-Mar-17 | Market Sale | 1,265 | $19.00 | $24,035.00 | (3%) 38.39K to 37.13K | 94% |
| 31-Jan-17 8:31 PM View: | Aravive, Inc. (ARAV) | 30-Jan-17 | Market Sale | 1,474 | $13.85 | $20,417.80 | (4%) 39.87K to 38.39K | 92% |
| 31-Jan-17 8:31 PM View: | Aravive, Inc. (ARAV) | 27-Jan-17 | Grant | 20,600 | -- | -- | 107% 19.27K to 39.87K | |
| 13-Oct-16 5:57 PM View: | Aravive, Inc. (ARAV) | 11-Oct-16 | Grant | 5,000 | -- | -- | 35% 14.27K to 19.27K | |
| 01-Feb-16 7:15 PM View: | Aravive, Inc. (ARAV) | 28-Jan-16 | Grant | 13,000 | -- | -- | 1028% 1.26K to 14.27K |